Brief: Asit Biotech Significantly Moves Forward In The Preparation Of The Clinical Development Plan Of Gp-Asit+ In The Us
06/12/2017 06:01
Asit Biotech Sa ASIT.BR :
* ASIT BIOTECH SIGNIFICANTLY MOVES FORWARD IN THE
PREPARATION OF
THE CLINICAL DEVELOPMENT PLAN OF GP-ASIT+ IN THE US
Source text for Eikon: ID:nBw8RGs4ya
Further company coverage: ASIT.BR
Recent news on European Medical Solutions SA
See all newsBrief: DMS Imaging H1 EBITDA Rises To EUR 2.2 Million
Brief: DMS Imaging Announces Resumption Of Project To Transfer Its Listing Securities On Euronext Growth Market In Paris And Brussels
Brief: DMS Imagining Announces End Of Litigation With Thierry Legon
Brief: DMS Imaging Sees 2023 Revenue At 40 Million Euros
Brief: DMS Imaging Says Fujifilm Healthcare Italy Wins Tender For Its Radiology Tables